Many people are now arriving in France, after leaving their country of origin, fleeing war or extreme poverty. Whether they are migrants or immigrants, these populations are exposed to precarious circumstances and difficult living conditions. What does this mean for their health?
The latest issue of Science & Santé magazine dedicates 2 pages to this subject:
According to Jean-Francois Delfraissy, Director of the Theme-Based Institute of Immunology, Inflammation, Infectiology and Microbiology: “the health issues concerning these populations is a societal problem, which should be tackled by academics. They should aim to provide political decision-makers with a scientific perspective.“
(Français) Des chercheurs lillois (Inserm, Université de Lille, Institut Pasteur de Lille, CNRS)* ont inventé un prototype de médicament (SMARt-420**) capable de supprimer la résistance à l’éthionamide, un antibiotique utilisé pour traiter la tuberculose. Ces travaux sont publiés dans la revue Science*** ...